Sanofi to present new clinical data, including results from the investigational new insulin U300, at the American Diabetes Association 73rd Scientific Sessions

Nyheten uppdaterades 2013-06-18 14:17

Paris,
France – June 18, 2013
(EURONEXT : SAN and
NYSE : SNY) announced today that clinical data highlighting the company’s
ongoing commitment to advancing diabetes care will be presented at the American
Diabetes Association (ADA) 73rd Scientific Sessions in Chicago, USA
(June 21−25, 2013). In total, more than
60 representing…

Källa: Mynewsdesk news release

Lämna gärna en kommentar